1. Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities
   Miriam Grazia Ferrara et al, 2021, Frontiers in Oncology CrossRef
2. Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments
   Masayo Yoshimura et al, 2021, Frontiers in Oncology CrossRef
3. Case report of a mixed pulmonary large cell neuroendocrine carcinoma
   Xiaoying Quan et al, 2022, Oncology and Translational Medicine CrossRef
4. The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the Lung
   Catalin Buium et al, 2023, Current Oncology CrossRef
5. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)
   Wenying Peng et al, 2022, The Oncologist CrossRef
6. Diagnostic criteria and evolving molecular characterisation of pulmonary neuroendocrine carcinomas
   Jessica F Williams et al, 2022, Histopathology CrossRef
7. Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma
   Siyu Zhu et al, 2024, Frontiers in Medicine CrossRef
8. Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges
   Elisa Andrini et al, 2022, Journal of Clinical Medicine CrossRef
9. New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management
   Jules L Derks et al, 2018, Journal of Thoracic Oncology CrossRef
10. Effect of Adjuvant and Palliative Chemotherapy in Large Cell Neuroendocrine Carcinoma of the Lung: A Systematic Review and Meta-Analysis
    Hao Chen et al, 2021, Cancers CrossRef
11. Latest advances in management of small cell lung cancer and other neuroendocrine tumors of the lung
    Hussein A. Assi et al, 2020, Cancer Treatment and Research Communications CrossRef
12. Complete remission of combined pulmonary large cell neuroendocrine carcinoma: a case report
    Jian Xu et al, 2021, Journal of International Medical Research CrossRef
13. Dramatic response to alectinib in an ALK‐positive LCNEC patient with a poor performance status: A case report
    Kazuki Masuda et al, 2021, Respirology Case Reports CrossRef
14. Response to selpercatinib in a patient with RET fusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report
    Aakriti Arora et al, 2023, Frontiers in Oncology CrossRef
15. Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases – data from a tertiary care center
    Petar Popov et al, 2024, Clinical & Experimental Metastasis CrossRef
16. Treatment of lung large cell neuroendocrine carcinoma
    Giuseppe Lo Russo et al, 2016, Tumor Biology CrossRef
17. Molecular Profiling and Survival of Completely Resected Primary Pulmonary Neuroendocrine Carcinoma
    Guangyuan Lou et al, 2017, Clinical Lung Cancer CrossRef
18. BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature
    Gianluca Ricco et al, 2023, Anti-Cancer Drugs CrossRef